Joel Greenblatt’s NEVRO CORP. NVRO Stock Holding History

Joel Greenblatt’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,930	Closed	-$269K	–	1114
2020 Q3	$269K	Sell	1,930 -9,677	-83%	-$1.29M	0.01%	859
2020 Q2	$1.39M	Buy	11,607 +4,742	+69%	+$562K	0.04%	485
2020 Q1	$686K	Buy	6,865 +266	+4%	+$32K	0.02%	649
2019 Q4	$776K	Buy	+6,599	New	+$654K	0.01%	680
2018 Q2	–	Sell	-9,622	Closed	-$834K	–	1071
2018 Q1	$834K	Buy	+9,622	New	+$777K	0.01%	642
2017 Q2	–	Sell	-9,939	Closed	-$931K	–	1110
2017 Q1	$931K	Buy	+9,939	New	+$900K	0.01%	683
2016 Q4	–	Sell	-9,589	Closed	-$1M	–	1074
2016 Q3	$1M	Sell	9,589 -2,335	-20%	-$211K	0.01%	603
2016 Q2	$880K	Buy	+11,924	New	+$809K	0.01%	644
2015 Q2	–	Sell	-7,742	Closed	-$371K	–	1062
2015 Q1	$371K	Buy	7,742 +1,684	+28%	+$73.1K	﹤0.01%	757
2014 Q4	$234K	Buy	+6,058	New	+$191K	﹤0.01%	888

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Joel Greenblatt's NVRO Position: Q4 2020 in Review

Joel Greenblatt sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 1,930 shares — an estimated $269K sold.

Joel Greenblatt first reported a position in NVRO in Q4 2014 and held it in 10 quarters. The position peaked at $1.39M in Q2 2020. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

Joel Greenblatt reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
Joel Greenblatt sold 1,930 NEVRO CORP. shares in Q4 2020, an estimated $269K.
Joel Greenblatt first reported a position in NEVRO CORP. in Q4 2014 and held it in 10 quarters.
Joel Greenblatt's NEVRO CORP. position peaked at $1.39M in Q2 2020.
226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Gotham Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.